Evaluation of Cognitive State in Seniors Using Neurosteer EEG System
1 other identifier
observational
77
1 country
1
Brief Summary
This is an observational study. Patients who fulfill all inclusion criteria and none of the exclusion criteria will be enrolled in the study, be neurologically evaluated and will go through EEG recordings while listening to an auditory cognitive assessment tool and preforming tasks. EEG recordings will be analyzed using proprietary computational analyses.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 31, 2022
CompletedFirst Submitted
Initial submission to the registry
August 29, 2022
CompletedFirst Posted
Study publicly available on registry
September 6, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 27, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
August 27, 2023
CompletedResults Posted
Study results publicly available
May 6, 2024
CompletedMay 6, 2024
August 1, 2022
1.2 years
August 29, 2022
November 16, 2023
November 16, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Correlation Between Cognition Level Changes as Evaluated by Current Clinical Tools (i.e. MMSE, MoCA) and Brain Activity Features Extracted Using the Neurosteer Technology.
Cognition level changes will be evaluated by: 1. Mini Mental State Examination (MMSE). A commonly used assessment tool that evaluates cognitive functioning and produces a total possible score of 30 points. Patients who score below 24 are typically suspected of cognitive decline. 2. Montreal Cognitive Assessment (MoCA). A commonly used assessment tool that evaluates cognitive functioning. The maximum score is 30, with a score of 26 or higher considered cognitively healthy. 3. Neurosteer system (single channel EEG recording during cognitive auditory tasks). Using data analysis (a variant of the wavelet packet analysis and the best basis algorithm), the EEG signal is transformed into brain activity features (e.g. ST4, A0). Pearson correlation will be calculated between the mean activity of the EEG features and individual's MMSE and MoCA scores.
MMSE and MoCA scores will be taken from previous evaluation performed in the institute. Through study completion, brain activity features will be assessed twice within 7 days using the Neurosteer EEG system.
Study Arms (1)
Patients
Patients who are assessed by the clinical staff using Mini-Mental State Exam (MMSE) and Montreal-Cognitive-Assessment-Test(MoCA)
Interventions
The system is composed of hardware and software modules that facilitate the capture and interpretation of electrophysiological data as well as enable viewing the processed data in real time and offline. An electrode patch is attached on the subject's forehead to capture the electrophysiological signal. The signal is sent via low energy Bluetooth to an EEG Monitor. The signal is then sent via Wi-Fi to the cloud where the data is stored on a HIPAA compliant server. Data analysis performed in the cloud transforms the electrophysiological signal into easily readable data of brain activity.
Eligibility Criteria
The study population is comprised of patients from the inpatient rehabilitation department at Dorot Geriatric Medical Center.
You may qualify if:
- Men and women over the age of 50.
- MMSE ≥ 10
- Patient is able to collaborate.
- No seizure events.
You may not qualify if:
- Advanced stage of cognitive decline (MMSE \< 10).
- Any verbal or non-verbal form of objection from patient or form patient's family member or significant other.
- Significant hearing impairments.
- Significant vision impairments.
- Damage to integrity of scalp and/or skull.
- Skin irritation in the facial and forehead area.
- Epilepsy or seizure activity.
- History of drug abuse.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Neurosteer Ltd.lead
Study Sites (1)
Dorot - Netanya Geriatric Medical Center
Netanya, 42420, Israel
Related Publications (3)
Molcho L, Maimon NB, Regev-Plotnik N, Rabinowicz S, Intrator N, Sasson A. Single-Channel EEG Features Reveal an Association With Cognitive Decline in Seniors Performing Auditory Cognitive Assessment. Front Aging Neurosci. 2022 May 30;14:773692. doi: 10.3389/fnagi.2022.773692. eCollection 2022.
PMID: 35707705BACKGROUNDMaimon NB, Bez M, Drobot D, Molcho L, Intrator N, Kakiashvilli E, Bickel A. Continuous Monitoring of Mental Load During Virtual Simulator Training for Laparoscopic Surgery Reflects Laparoscopic Dexterity: A Comparative Study Using a Novel Wireless Device. Front Neurosci. 2022 Jan 20;15:694010. doi: 10.3389/fnins.2021.694010. eCollection 2021.
PMID: 35126032BACKGROUNDCurcic J, Vallejo V, Sorinas J, Sverdlov O, Praestgaard J, Piksa M, Deurinck M, Erdemli G, Bugler M, Tarnanas I, Taptiklis N, Cormack F, Anker R, Masse F, Souillard-Mandar W, Intrator N, Molcho L, Madero E, Bott N, Chambers M, Tamory J, Shulz M, Fernandez G, Simpson W, Robin J, Snaedal JG, Cha JH, Hannesdottir K. Description of the Method for Evaluating Digital Endpoints in Alzheimer Disease Study: Protocol for an Exploratory, Cross-sectional Study. JMIR Res Protoc. 2022 Aug 10;11(8):e35442. doi: 10.2196/35442.
PMID: 35947423BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Nathan Intrator, Prof.
- Organization
- Neurosteer
Study Officials
- PRINCIPAL INVESTIGATOR
Ady Sasson
Dorot, Geriatric Medical Center
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 29, 2022
First Posted
September 6, 2022
Study Start
May 31, 2022
Primary Completion
August 27, 2023
Study Completion
August 27, 2023
Last Updated
May 6, 2024
Results First Posted
May 6, 2024
Record last verified: 2022-08
Data Sharing
- IPD Sharing
- Will not share